Hims & Hers Health Inc (NYSE:HIMS)
$ 20.76 0 (0%) Market Cap: 4.49 Bil Enterprise Value: 4.28 Bil PE Ratio: 259.50 PB Ratio: 12.43 GF Score: 54/100

Hims & Hers Health Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 11, 2021 / 09:20PM GMT
Release Date Price: $7.7 (-3.99%)
Jailendra P. Singh;dit Suisse AG;Andrew Dudum
CrÃ;Research Division - Research Analyst;Hims & Hers Health, Inc. - Co-Founder,

© -

All right. So welcome to the last session of our health care conference, and we probably saved the best for the last here. Again, I'm Jailendra Singh, health care technology and distribution analyst at Crédit Suisse. Thanks, everyone, for joining us for this session.

So we have Hims & Hers for this session. And from the company, we have Andrew Dudum, CEO. Hims & Hers is a multi-specialty telehealth platform, connecting consumers to licensed health care professionals, enabling them to access high-quality medical care for numerous condition related to primary care, mental health, sexual health, dermatology and more. We are going to do this in a fireside chat format. I have some prepared questions, which I plan to cover. But if anyone from the audience has a question, please e-mail them to me at [email protected].

Andrew, thanks so much for doing this. We appreciate it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot